Last filing: Mar 2, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | Director | Feb 26, 2026 | Mar 2, 2026 |
| Bio-Techne (TECH) | Director | Jul 2, 2019 | Nov 3, 2025 |
| Bristol Myers Squibb (BMY) | Former EVP & President, Research | Nov 27, 2019 | May 4, 2023 |
Also a director at
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 30, 2025, Bio-Techne: 1,640 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.